GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
110 hedge funds and large institutions have $320M invested in GenMark Diagnostics, Inc in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
+4
Holders Change %
+3.77%
% of All Funds
2.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
43
Reduced
25
Closed
12
Calls
–
Puts
$46K
Net Calls
-$46K
Net Calls Change
+$3K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$13.8M |
| 2 |
BlackRock
New York
|
+$2.57M |
| 3 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$2.17M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.74M |
| 5 |
QI
QS Investors
New York
|
+$1.65M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$21.8M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.45M |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$1.62M |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.61M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.3M |
